Resultats de la cerca - Akazawa, Yuki
- Mostrar 1 - 20 resultats de 20
-
1
-
2
-
3
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report per Edahiro, Ryuya, Ishijima, Mikako, Kurebe, Hiroyuki, Nishida, Kohei, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, Masahide
Publicat 2019Text -
4
Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series per Kanazu, Masaki, Edahiro, Ryuya, Krebe, Hiroyuki, Nishida, Kohei, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2018Text -
5
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression per Uenami, Takeshi, Ishijima, Mikako, Kanazu, Masaki, Kurebe, Hiroyuki, Edahiro, Ryuya, Nishida, Kohei, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2018Text -
6
Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective... per Yamamoto, Yuji, Yano, Yukihiro, Kuge, Tomoki, Okabe, Fukuko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2020Text -
7
EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib per Hara, Reina, Kanazu, Masaki, Iwai, Ami, Kuge, Tomoki, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2021Text -
8
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report per Kuge, Tomoki, Okabe, Fukuko, Yamamoto, Yuji, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2021Text -
9
Case series of pleomorphic carcinomas of the lung treated with nivolumab per Kanazu, Masaki, Uenami, Takeshi, Yano, Yukihiro, Nakatsubo, Saeko, Hosono, Yuki, Ishijima, Mikako, Akazawa, Yuki, Yamaguchi, Toshihiko, Urasaki, Koji, Mori, Masahide, Yokota, Soichiro
Publicat 2017Text -
10
Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient per Hosono, Yuki, Sawa, Nobuhiko, Nakatsubo, Saeko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, Masahide, Yamaguchi, Toshihiko, Yokota, Soichiro
Publicat 2017Text -
11
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316) per Tachihara, Motoko, Negoro, Shunichi, Inoue, Takako, Tamiya, Motohiro, Akazawa, Yuki, Uenami, Takeshi, Urata, Yoshiko, Hattori, Yoshihiro, Hata, Akito, Katakami, Nobuyuki, Yokota, Soichiro
Publicat 2018Text -
12
Piezo type mechanosensitive ion channel component 1 functions as a regulator of the cell fate determination of mesenchymal stem cells per Sugimoto, Asuna, Miyazaki, Aya, Kawarabayashi, Keita, Shono, Masayuki, Akazawa, Yuki, Hasegawa, Tomokazu, Ueda-Yamaguchi, Kimiko, Kitamura, Takamasa, Yoshizaki, Keigo, Fukumoto, Satoshi, Iwamoto, Tsutomu
Publicat 2017Text -
13
Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwen... per Akazawa, Yuki, Higashiyama, Masahiko, Nishino, Kazumi, Uchida, Jyunji, Kumagai, Toru, Inoue, Takako, Fujiwara, Ayako, Tokunaga, Toshiteru, Okami, Jiro, Imamura, Fumio, Kodama, Ken, Kobayashi, Hisayuki
Publicat 2017Text -
14
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study per Yano, Yukihiro, Kurebe, Hiroyuki, Edahiro, Ryuya, Hosono, Yuki, Nakatsubo, Saeko, Nishida, Kohei, Sawa, Nobuyuki, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Publicat 2018Text -
15
Coordination of WNT signaling and ciliogenesis during odontogenesis by piezo type mechanosensitive ion channel component 1 per Miyazaki, Aya, Sugimoto, Asuna, Yoshizaki, Keigo, Kawarabayashi, Keita, Iwata, Kokoro, Kurogoushi, Rika, Kitamura, Takamasa, Otsuka, Kunihiro, Hasegawa, Tomokazu, Akazawa, Yuki, Fukumoto, Satoshi, Ishimaru, Naozumi, Iwamoto, Tsutomu
Publicat 2019Text -
16
Fibroblast growth factor 2 suppresses the expression of C-C motif chemokine 11 through the c-Jun N-terminal kinase pathway in human dental pulp-derived mesenchymal stem cells per Kurogoushi, Rika, Hasegawa, Tomokazu, Akazawa, Yuki, Iwata, Kokoro, Sugimoto, Asuna, Yamaguchi-Ueda, Kimiko, Miyazaki, Aya, Narwidina, Anrizandy, Kawarabayashi, Keita, Kitamura, Takamasa, Nakagawa, Hiroshi, Iwasaki, Tomonori, Iwamoto, Tsutomu
Publicat 2021Text -
17
Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L) per Kato, Ryoji, Hayashi, Hidetoshi, Chiba, Yasutaka, Miyawaki, Eriko, Shimizu, Junichi, Ozaki, Tomohiro, Fujimoto, Daichi, Toyozawa, Ryo, Nakamura, Atsushi, Kozuki, Toshiyuki, Tanaka, Kentaro, Teraoka, Shunsuke, Usui, Kazuhiro, Nishino, Kazumi, Hataji, Osamu, Ota, Keiichi, Ebi, Noriyuki, Saeki, Sho, Akazawa, Yuki, Okuno, Motoyasu, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicat 2020Text -
18
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ03... per Tsubata, Yukari, Watanabe, Kana, Saito, Ryota, Nakamura, Atsushi, Yoshioka, Hiroshige, Morita, Mami, Honda, Ryoichi, Kanaji, Nobuhiro, Ohizumi, Satoshi, Jingu, Daisuke, Nakagawa, Taku, Nakazawa, Kensuke, Mouri, Atsuto, Takeuchi, Susumu, Furuya, Naoki, Akazawa, Yuki, Miura, Kiyotaka, Ichihara, Eiki, Maemondo, Makoto, Morita, Satoshi, Kobayashi, Kunihiko, Isobe, Takeshi
Publicat 2021Text -
19
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI tr... per Tsubata, Yukari, Watanabe, Kana, Saito, Ryota, Nakamura, Atsushi, Yoshioka, Hiroshige, Morita, Mami, Honda, Ryoichi, Kanaji, Nobuhiro, Oizumi, Satoshi, Jingu, Daisuke, Nakagawa, Taku, Nakazawa, Kensuke, Mouri, Atsuto, Takeuchi, Susumu, Furuya, Naoki, Akazawa, Yuki, Miura, Kiyotaka, Ichihara, Eiki, Maemondo, Makoto, Morita, Satoshi, Kobayashi, Kunihiko, Isobe, Takeshi
Publicat 2022Text -
20
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients per Osa, Akio, Uenami, Takeshi, Koyama, Shohei, Fujimoto, Kosuke, Okuzaki, Daisuke, Takimoto, Takayuki, Hirata, Haruhiko, Yano, Yukihiro, Yokota, Soichiro, Kinehara, Yuhei, Naito, Yujiro, Otsuka, Tomoyuki, Kanazu, Masaki, Kuroyama, Muneyoshi, Hamaguchi, Masanari, Koba, Taro, Futami, Yu, Ishijima, Mikako, Suga, Yasuhiko, Akazawa, Yuki, Machiyama, Hirotomo, Iwahori, Kota, Takamatsu, Hyota, Nagatomo, Izumi, Takeda, Yoshito, Kida, Hiroshi, Akbay, Esra A., Hammerman, Peter S., Wong, Kwok-kin, Dranoff, Glenn, Mori, Masahide, Kijima, Takashi, Kumanogoh, Atsushi
Publicat 2018Text